Related references
Note: Only part of the references are listed.Effects of EpCAM overexpression on human breast cancer cell lines
Johanna M. Gostner et al.
BMC CANCER (2011)
Rare cell capture in microfluidic devices
Erica D. Pratt et al.
CHEMICAL ENGINEERING SCIENCE (2011)
Circulating Tumor Cells as Biomarkers in Prostate Cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2011)
High Level PSMA Expression Is Associated With Early PSA Recurrence in Surgically Treated Prostate Cancer
Sarah Minner et al.
PROSTATE (2011)
All circulating EpCAM+CK+CD45-objects predict overall survival in castration-resistant prostate cancer
F. A. W. Coumans et al.
ANNALS OF ONCOLOGY (2010)
Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells
Sabine Riethdorf et al.
TOWARD PERSONALIZED MEDICINE FOR CANCER (2010)
Circulating tumor cells: a window into cancer biology and metastasis
Shyamala Maheswaran et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
Jason P. Gleghorn et al.
LAB ON A CHIP (2010)
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Shannon L. Stott et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Circulating tumour cells in cancer patients: challenges and perspectives
Klaus Pantel et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
D. Olmos et al.
ANNALS OF ONCOLOGY (2009)
Circulating tumor cells in metastatic inflammatory breast cancer
M. Mego et al.
ANNALS OF ONCOLOGY (2009)
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Markus Munz et al.
CANCER RESEARCH (2009)
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers
Michael C. Haffner et al.
HUMAN PATHOLOGY (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Sebastian Mannweiler et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Expression of the Gastrin-Releasing Peptide Receptor, the Prostate Stem Cell Antigen and the Prostate-Specific Membrane Antigen in Lymph Node and Bone Metastases of Prostate Cancer
Hildo J. K. Ananias et al.
PROSTATE (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Immunohistochemical detection of carcinoma in radical prostatectomy specimens following hormone therapy
Tomomi Kusumi et al.
PATHOLOGY INTERNATIONAL (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
Sven Perner et al.
HUMAN PATHOLOGY (2007)
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
David R. Shaffer et al.
CLINICAL CANCER RESEARCH (2007)
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
JR Mesters et al.
EMBO JOURNAL (2006)
Enrichment using antibody-coated microfluidic chambers in shear flow: Model mixtures of human lymphocytes
A Sin et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
Is prostate-specific membrane antigen a multifunctional protein?
AK Rajasekaran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase
MI Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Circulating tumor cells predict survival in patients with metastatic prostate cancer
JG Moreno et al.
UROLOGY (2005)
Effect of flow and surface conditions on human lymphocyte isolation using microfluidic chambers
SK Murthy et al.
LANGMUIR (2004)
A rare-cell detector for cancer
RT Krivacic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen
NH Bander et al.
SEMINARS IN ONCOLOGY (2003)
Programmable modification of cell adhesion and zeta potential in silica microchips
BJ Kirby et al.
LAB ON A CHIP (2003)